[말레이시아인턴] 한국업체 수요조사(2)_뎅기열 진단키트 조사

과거 다른 블로그에 포스팅했던 자료들을 옮기는 중입니다.

---

본 자료는 개인이 2016년 말레이시아에서 인턴으로 근무하던 시기에 작성한 자료로 현재 2021년에는 다른 점들이 있습니다. 제가 아는 선에서 달라진 부분에 대해서는 별도의 표시를 해두도록 하겠습니다. 

 

현지에서 얻어진 수요조사를 통해 관련 수요의 한국업체를 찾는 작업을 2달간 진행했었습니다.

보고서형식으로 작성되었으며, 이미 상당기간 시간이 지났으며 이미 대부분 공개된 정보입니다. 간단하게 정리가 되어있어 블로그에 포스팅합니다. 

 

본 자료는 시기가 지난 정보임을 다시 한번 더 강조합니다.

 

Research for Dengue fever Kit company(2016ver)

Dengue fever	Dengue fever is a mosquito-borne tropical disease caused by the dengue virus. Symptoms typically begin three to fourteen days after infection. This may include a high fever, headache, vomiting, muscle and joint pains, and a characteristic skin rash. Recovery generally takes less than two to seven days. In a small proportion of cases, the disease develops into the life-threatening dengue hemorrhagic fever, resulting in bleeding, low levels of blood platelets and blood plasma leakage, or into dengue shock syndrome, where dangerously low blood pressure occurs. Dengue is spread by several species of mosquito of the Aedes type, principally A. aegypti. The virus has five different types; infection with one type usually gives lifelong immunity to that type, but only short-term immunity to the others. Subsequent infection with a different type increases the risk of severe complications. A number of tests are available to confirm the diagnosis including detecting antibodies to the virus or its RNA.
Influence	High fever, muscle pain, arthralgia, headache, vomiting, skin rash
Prevent & treat	A novel vaccine for dengue fever has been approved in three countries, but it is not yet commercially available. Prevention is by reducing mosquito habitat and limiting exposure to bites. This may be done by getting rid of or covering standing water and wearing clothing that covers much of the body. Treatment of acute dengue is supportive and includes giving fluid either by mouth or intravenously for mild or moderate disease. For more severe cases blood transfusion may be required. About half a million people require admission to hospital a year. Nonsteroidal anti-inflammatory drug (NSAIDs) such as ibuprofen should not be used.

NAME	PRODUCTION COMPANY	FEATURE	ETC
LabGun™ PCR Kit Dengue(RT)	Labgenomics	PCR kit
CareStart™ Dengue Combo (NS1+IgM/IgG)	ACCESSBIO	Rapid kit Rapid kit	Same company group
Dengue Combo NS1 & IgM/IgG	WELLSBIO
Dengue IgM/IgG
Dengue NS1

-      Related Product

1.    Labgenomics

Company/	Labgenomics			Homepage	http://www.labgenomics.co.kr
Location/	700, Daewangpangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Korea 289, Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Korea
Contact/	TEL.031-628-0702  /  FAX.031-628-0701
History/	2001. 10 foundation
Product		FEATURE
LabGun™ PCR Kit Dengue(RT)		-LabGun™ PCR Kit Dengue(RT) can detect 4 kinds of Dengue virus in infection blood and identify the kind of the Dengue virus
		WEB-SITE	http://www.labgenomics.co.kr/eng/product/product01_03.php

 

2.    ACCESSBIO(same group with WELLSBIO)

Company/	ACCESSBIO			Homepage	http://www.accessbio.net/
Location/	ACCESS BIO, INC.	65 Clyde Rd. Suite A, Somerset, NJ 08873, USA
	WELLS BIO, INC.	B-1405 ho, 401, Yangcheon-ro, Gangseo-gu, Seoul, Korea (listed stock in Korea)
	ACCESS BIO, INC.	Ethiopian Branch Yeka Sub-City, Kebele 16, House No.-New. Addis Ababa, Ethiopia
History/	2002 company foundation
Product		FEATURE
CareStart™ Dengue Combo (NS1+IgM/IgG)		-CareStart™ Dengue Combo (NS1 Ag+IgM/IgG) is a rapid diagnostic test that can simultaneously detect dengue virus in all clinical stages using both dengue NS1 antigen and anti-dengue antibodies (IgM/IgG) with one device. -Diagnosis of dengue infection from acute to convalescent stage -Detection of all four dengue serotypes from serum, plasma, or whole blood -True point-of-care test with no specimen preparation
		WEB-SITE	http://www.accessbio.net/eng/products/products01_03.asp

 

3.    WELLSBIO(same group with the ACCESSBIO)

Company/	WELLSBIO			Homepage	http://www.accessbio.net/
Location/	ACCESS BIO, INC.		65 Clyde Rd. Suite A, Somerset, NJ 08873, USA
	WELLS BIO, INC.		B-1405 ho, 401, Yangcheon-ro, Gangseo-gu, Seoul, Korea (listed stock in Korea)
	ACCESS BIO, INC.		Ethiopian Branch Yeka Sub-City, Kebele 16, House No.-New. Addis Ababa, Ethiopia
History/	2013. 10 company foundation
Product		FEATURE
Dengue Combo NS1&IgM/IgG		-Detection of both dengue NS1 antigen and anti-dengue antibodies (IgM/IgG) -Suitable for all clinical stages of dengue infections
		WEB-SITE	http://www.wellsbio.net/eng/goods/view.asp?idx=2&category=5&search_type=0&search_word=&page_size=8&page=1
Dengue IgM/IgG		-Suitable for presumptive differentiation between primary and secondary dengue infections
		WEB-SITE	http://www.wellsbio.net/eng/goods/view.asp?idx=17&category=5&search_type=0&search_word=&page_size=8&page=1
Dengue NS1		-Suitable for early diagnosis of acute dengue infection -Can be used from the day 1 after onset of fever
		WEB-SITE	http://www.wellsbio.net/eng/goods/view.asp?idx=16&category=5&search_type=0&search_word=&page_size=8&page=1